Supriya Lifescience Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million)
Supriya Lifescience Ltd · Outcome · 06 Nov 2026, 6:20 pm
Supriya Lifescience Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million) ■ Revenue: 2,063 (+3.2% YoY | +8.7% QoQ) ■ EBITDA: 454 (-37.5% YoY | -4.3% QoQ) ■ EBITDA Margin (%): 22.0 (-1435 bps YoY | -300 bps QoQ) ■ PAT: 293 (-42.0% YoY | +21.7% QoQ) ■ EPS (INR): 3.63 (-42.1% YoY | +21.4% QoQ)
Original exchange filing (PDF)
More announcements from Supriya Lifescience Ltd
- Earnings Call Transcript is enclosed herewith. · 13 Nov 2026
- Outcome of the Results Earning Call for Quarter and Half year ended September 30, 2026 is enclosed herewith. · 07 Nov 2026
- Press Release is enclosed herewith. · 07 Nov 2026
- Investor Presentation is enclosed for the Results Earnings Call for quarter and half year ended September 30, 2026. · 06 Nov 2026
- Change In Management - Appointment of Senior Management Personnel of the Company. · 06 Nov 2026
- Please find enclosed. · 06 Nov 2026
- Supriya Lifescience Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 06 Nov 2026
- Enclosed herewith is the announcement under Regulation 30 of SEBI (LODR) Regulations, 2015. Kindly take the same on record. · 03 Nov 2026
